Do atypical features affect outcome in depressed outpatients treated with citalopram?
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Depressed patients with atypical features have an earlier onset of depression, a more chronic course of illness, several distinctive biological and familial features, and a different treatment response than those without atypical features. The efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) have not been fully evaluated in depression with atypical features. This report evaluates data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study to determine whether depressed outpatients with and without atypical features respond differently to the SSRI citalopram. Treatment-seeking participants with non-psychotic major depressive disorder were recruited from primary- and psychiatric-care settings. The presence/absence of atypical features was approximated using baseline ratings on the 30-item Inventory of Depressive Symptomatology - Clinician-rated. Following baseline assessments, participants received citalopram up to 60 mg/d for up to 14 wk. Baseline sociodemographic and clinical characteristics, and treatment outcomes, were compared between participants with and without atypical features. Of the 2876 evaluable STAR*D participants, 541 (19%) had atypical features. Participants with atypical features were significantly more likely to be female, younger, unemployed, have greater physical impairment, a younger age of depression onset, a longer index episode, greater depressive severity, and more concurrent anxiety diagnoses. Those with atypical features had significantly lower remission rates, although this difference was no longer present after adjustment for baseline differences. Depressed patients with atypical features are less likely to remit with citalopram than those without atypical features. This finding is probably due to differences in baseline characteristics other than atypical symptom features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 2×
“…approach in which the QIDS-C16 (Rush et al. 2003, 2006) and the Frequency, Intensity and Burden of Side Effects Rating (FIBSER; Wisniewski et al. 2006) were used to ensure that each participant received an adequate dose and duration of treatment while minimizing side-effects (Trivedi et al. 2006).”
BackgroundMethodSelf-citationRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · cited 5×
“The CRC completed the HAMD17 and the 16-item Quick Inventory of Depressive Symptomatology – Clinician-rated (QIDS-C16 ; Rush et al. 2003 ; Trivedi et al. 2004), and the participant completed the QIDS self-report (QIDS-SR16 ; Rush et al. 2003 ; Trivedi et al. 2004) for assessment of depressive symptom severity.”
MethodInfluentialSelf-citationEstablishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia
ROBINS, E., & GUZE, S. B. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.126.7.983 · Cited by 2,243 · cited 1×
“Because it has been subjected to a wide variety of proposed validating tests (Klein, 1989 ; Rabkin et al. 1996 ; Robins & Guze, 1970 ; Stewart et al. 1993) we will focus on the ‘Columbia criteria’ for depression with atypical features.”
BackgroundThe Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177 · cited 1×
“Within 72 h of the baseline visit, a ROA contacted the participant by telephone to complete the HAMD17, the 30-item Inventory of Depressive Symptomatology – Clinician-rated (IDS-C30 ; Rush et al. 1986, 1996 ; Trivedi et al. 2004), and a 5-item Income and Public Assistance Questionnaire (IPAQ).”
MethodSelf-citationMiller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990 · cited 4×
“Cumulative Illness Rating Scale.”
MethodInfluentialSequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076 · cited 2×
“The population and methods of STAR*D including enrolment, inclusion and exclusion criteria, and data collection are detailed elsewhere (Fava et al. 2003; Rush et al. 2004).”
MethodSelf-citationTRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968 · cited 3×
“The CRC completed the HAMD17 and the 16-item Quick Inventory of Depressive Symptomatology – Clinician-rated (QIDS-C16 ; Rush et al. 2003 ; Trivedi et al. 2004), and the participant completed the QIDS self-report (QIDS-SR16 ; Rush et al. 2003 ; Trivedi et al. 2004) for assessment of depressive…”
MethodSelf-citationFAVA, M., ALPERT, J. E., CARMIN, C. N., WISNIEWSKI, S. R., TRIVEDI, M. H., BIGGS, M. M., SHORES-WILSON, K., MORGAN, D., SCHWARTZ, T., BALASUBRAMANI, G. K., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291704002612 · Cited by 406
Self-citationZimmerman, M., & Mattia, J. I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.787 · Cited by 375 · cited 2×
“Concurrent psychiatric symptoms were identified using the Psychiatric Diagnostic Screening Questionnaire (PDSQ; Zimmerman & Mattia, 2001a) obtained at Downloaded from https://academic.oup.com/ijnp/article-abstract/13/1/15/646786 by guest on 30 July 2018 baseline.”
MethodTranylcypromine versus imipramine in anergic bipolar depression
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.7.910 · Cited by 360
Cited by
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Conversely, patients with atypical depression appear less likely to remit with the SSRI citalopram than those without atypical features (Stewart et al., 2010; Trivedi et al., 2006).”
BackgroundUher, R., Perlis, R. H., Henigsberg, N., Zobel, A., Rietschel, M., Mors, O., Hauser, J., Dernovsek, M. Z., Souery, D., Bajs, M., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711001905 · Cited by 420
“…et al. 2004) and anxious (Fava et al. 2008) depression predict treatment outcomes in some cohorts, inconsistent results have been reported for each (McGrath et al. 2000 ; Russell et al. 2001 ; Brown, 2007; McGrath et al. 2008 ; Thase, 2009 ; Nelson, 2010 ; Stewart et al. 2010 ; Uher et al. 2011).”
ResultThe vigilance regulation model of affective disorders and ADHD
Hegerl, U., & Hensch, T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.008 · Cited by 212
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial
Arnow, B. A., Blasey, C., Williams, L. M., Palmer, D. M., Rekshan, W., Schatzberg, A. F., Etkin, A., Kulkarni, J., Luther, J. F., & Rush, A. J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14020181 · Cited by 175
Self-citation
Metadata
- Authors
- Stewart, J. W., McGrath, P. J., Fava, M., Wisniewski, S. R., Zisook, S., Cook, I., Nierenberg, A. A., Trivedi, M. H., Balasubramani, G. K., Warden, D., Lesser, I., & John Rush, A.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-03
- Volume
- 13
- Issue
- 01
- Pages
- 15
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2159275391
- Cited by
- 64
- References
- 14
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do atypical features affect outcome in depressed outpatients treated with citalopram? https://app.cochat.ai/papers/10.1017/s1461145709000182
- The paper
- Stewart, J. W., McGrath, P. J., Fava, M., Wisniewski, S. R., Zisook, S., Cook, I., Nierenberg, A. A., Trivedi, M. H., Balasubramani, G. K., Warden, D., Lesser, I., & John Rush, A. (2010). Do atypical features affect outcome in depressed outpatients treated with citalopram? The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145709000182
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.